$1.59 Billion is the total value of Carlyle Group Inc.'s 32 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 52.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Quidelortho Corp | $597,341,173 | -35.0% | 12,460,183 | 0.0% | 37.66% | -14.7% | ||
| ZI | Sell | ZoomInfo Technologies Inc | $420,698,919 | -35.4% | 26,244,474 | -25.5% | 26.52% | -15.4% |
| Buy | Soleno Therapeutics Inc | $173,122,816 | +50.5% | 4,071,562 | +42.5% | 10.91% | +97.2% | |
| VTRU | Vitru Ltd | $94,009,389 | -4.5% | 6,246,471 | 0.0% | 5.93% | +25.2% | |
| VRNA | Verona Pharma Plcsponsored ads | $39,442,875 | -19.2% | 2,457,500 | 0.0% | 2.49% | +5.9% | |
| Sell | Getty Images Holdings Inc | $38,233,118 | -22.5% | 9,212,799 | -1.9% | 2.41% | +1.6% | |
| PHAT | Phathom Pharmaceuticals Inc | $37,101,133 | +16.2% | 3,496,808 | 0.0% | 2.34% | +52.4% | |
| New | Jasper Therapeutics Inc | $31,303,309 | – | 1,066,189 | +100.0% | 1.97% | – | |
| Hillevax Inc | $30,500,483 | +3.4% | 1,838,486 | 0.0% | 1.92% | +35.5% | ||
| GDS | GDS Hldgs Ltdsponsored ads | $27,082,952 | -27.1% | 4,072,624 | 0.0% | 1.71% | -4.4% | |
| SMHI | Seacor Marine Hldgs Inc | $18,319,446 | +10.7% | 1,314,164 | 0.0% | 1.16% | +45.1% | |
| New | Q32 Bio Inc | $18,073,925 | – | 1,102,741 | +100.0% | 1.14% | – | |
| INVH | Invitation Homes Inc | $17,003,775 | +4.4% | 477,500 | 0.0% | 1.07% | +36.9% | |
| CUBE | CubeSmart | $9,971,010 | -2.4% | 220,500 | 0.0% | 0.63% | +27.8% | |
| ACET | Buy | Adicet Bio Inc | $6,900,000 | +73.5% | 2,948,718 | +39.4% | 0.44% | +127.7% |
| DNUT | New | Krispy Kreme Inc | $5,191,295 | – | 340,748 | +100.0% | 0.33% | – |
| RPHM | Reneo Pharmaceuticals Inc | $4,453,279 | +3.1% | 2,698,957 | 0.0% | 0.28% | +35.1% | |
| EM | Smart Sh Global Ltdads | $3,162,231 | +31.2% | 4,810,209 | 0.0% | 0.20% | +71.6% | |
| New | Effector Therapeutics Inc | $2,721,593 | – | 192,884 | +100.0% | 0.17% | – | |
| Buy | Complete Solaria Inc | $2,715,066 | -36.2% | 4,936,483 | +79.8% | 0.17% | -16.6% | |
| SPRB | Spruce Biosciences Inc | $2,276,663 | -72.8% | 2,896,518 | 0.0% | 0.14% | -64.3% | |
| New | N-able Inc | $1,225,077 | – | 93,732 | +100.0% | 0.08% | – | |
| New | Solarwinds Corp | $1,182,936 | – | 93,735 | +100.0% | 0.08% | – | |
| AVGO | New | Broadcom Inc | $1,000,566 | – | 755 | +100.0% | 0.06% | – |
| New | Nu Hldgs Ltd | $863,028 | – | 72,341 | +100.0% | 0.05% | – | |
| NCNA | Nucana Plcsponsored adr | $845,333 | -12.6% | 3,333,333 | 0.0% | 0.05% | +12.8% | |
| DASH | New | DoorDash Inccl a | $572,364 | – | 4,156 | +100.0% | 0.04% | – |
| Spyre Therapeutics Inc | $364,790 | +78.9% | 9,620 | 0.0% | 0.02% | +130.0% | ||
| Meta Data Limitedsponsored ads | $240,610 | -21.4% | 314,400 | 0.0% | 0.02% | 0.0% | ||
| CFLT | New | Confluent Inc | $234,485 | – | 7,683 | +100.0% | 0.02% | – |
| Exicure Inc | $160,533 | -1.8% | 281,636 | 0.0% | 0.01% | +25.0% | ||
| Molecular Templates Inc | $28,666 | -41.9% | 13,333 | 0.0% | 0.00% | 0.0% | ||
| Exit | Effector Therapeutics Inc | $0 | – | -4,822,114 | -100.0% | -0.11% | – | |
| Exit | Jasper Therapeutics Inc | $0 | – | -8,761,891 | -100.0% | -0.32% | – | |
| VERA | Exit | Vera Therapeutics Inccl a | $0 | – | -1,438,155 | -100.0% | -1.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
| Seacor Marine Hldgs Inc | 25 | Q2 2024 | 1.7% |
| Enviva Partners LP | 21 | Q2 2020 | 31.5% |
| Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
| USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
| Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
| Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
| Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
| ZoomInfo Technologies Inc | 17 | Q2 2024 | 61.4% |
| Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | May 13, 2024 | 193,195 | 4.1% |
| Q32 Bio Inc. | March 29, 2024 | 1,102,741 | 9.2% |
| HilleVax, Inc. | February 12, 2024 | 1,838,486 | 3.8% |
| Jasper Therapeutics, Inc. | February 12, 2024 | 1,066,189 | 7.1% |
| MKS INSTRUMENTS INCSold out | February 12, 2024 | 0 | 0.0% |
| Phathom Pharmaceuticals, Inc. | February 12, 2024 | 3,496,808 | 6.1% |
| ZoomInfo Technologies Inc. | February 12, 2024 | 35,244,474 | 9.0% |
| Adicet Bio, Inc. | February 07, 2024 | 3,060,292 | 4.1% |
| CommScope Holding Company, Inc. | January 03, 2024 | 42,257,593 | 16.6% |
| Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-09-10 |
| N-PX | 2024-08-30 |
| 4 | 2024-08-28 |
| 4 | 2024-08-28 |
| 4 | 2024-08-28 |
| 4 | 2024-08-28 |
| 4 | 2024-08-28 |
| 144 | 2024-08-23 |
| 144 | 2024-08-23 |
| 4 | 2024-08-13 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.